Obesity and energy balance in GI cancer

Journal of Clinical Oncology

Volumn 34, Issue 35, 2016, Pages 4217-4224

  Brown, Justin C ^a,b   Meyerhardt, Jeffrey A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; CANCER PATIENT; CANCER PROGNOSIS; CANCER THERAPY; COLORECTAL CANCER; DIET; DIGESTIVE SYSTEM CANCER; ENERGY BALANCE; ESOPHAGUS CANCER; FUTUROLOGY; HUMAN; LIVER CELL CARCINOMA; OBESITY; ONCOLOGIST; PANCREAS CANCER; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SARCOPENIA; SARCOPENIC OBESITY; STOMACH CANCER; BODY MASS; COMPLICATION; ENERGY METABOLISM; GASTROINTESTINAL NEOPLASMS; OVERWEIGHT; PROGNOSIS; RISK FACTOR; SURVIVAL ANALYSIS;

BODY MASS INDEX; ENERGY METABOLISM; GASTROINTESTINAL NEOPLASMS; HUMANS; OBESITY; OVERWEIGHT; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 85002817159     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.66.8699     Document Type: Review

References (75)

1. Flegal KM, Carroll MD, Ogden CL, et al: Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241, 2010
2. Masters RK, Reither EN, Powers DA, et al: The impact of obesity on US mortality levels: The importance of age and cohort factors in population estimates. Am J Public Health 103:1895-1901, 2013
3. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65:5-29, 2015
4. Wolin KY, Carson K, Colditz GA: Obesity and cancer. Oncologist 15:556-565, 2010
5. Renehan AG, Tyson M, Egger M, et al: Bodymass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578, 2008
6. Demark-Wahnefried W, Platz EA, Ligibel JA, et al: The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev 21:1244-1259, 2012
7. Ibrahim MM: Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes Rev 11:11-18, 2010
8. Ligibel JA, Alfano CM, Courneya KS, et al: American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol 32:3568-3574, 2014
9. Ligibel JA, Alfano CM, Hershman D, et al: Recommendations for obesity clinical trials in cancer survivors: American Society of Clinical Oncology statement. J Clin Oncol 33:3961-3967, 2015
10. Yoon HH, Lewis MA, Shi Q, et al: Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol 29:4561-4567, 2011
11. Watanabe M, Ishimoto T, Baba Y, et al: Prognostic impact of body mass index in patients with squamous cell carcinoma of the esophagus. Ann Surg Oncol 20:3984-3991, 2013
12. Blom RL, Lagarde SM, Klinkenbijl JH, et al: A high body mass index in esophageal cancer patients does not influence postoperative outcome or longterm survival. Ann Surg Oncol 19:766-771, 2012
13. Hayashi Y, Correa AM, Hofstetter WL, et al: The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116:5619-5627, 2010
14. Dhar DK, Kubota H, Tachibana M, et al: Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology 59:18-23, 2000
15. Moriwaki Y, Kunisaki C, Kobayashi S, et al: Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy? Hepatogastroenterology 50:284-288, 2003
16. Ojima T, Iwahashi M, Nakamori M, et al: Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: An analysis of 689 consecutive cases managed by a single center. Arch Surg 144:351-358, 2009; discussion 358
17. Inagawa S, Adachi S, Oda T, et al: Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer. Gastric Cancer 3:141-144, 2000
18. Li XT, Tang L, Chen Y, et al: Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy. J Cancer Res Clin Oncol 141:1237-1247, 2015
19. Bouchard C: BMI, fat mass, abdominal adiposity and visceral fat: Where is the 'beef'? Int J Obes 31:1552-1553, 2007
20. Fleming JB, Gonzalez RJ, Petzel MQ, et al: Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 144:216-221, 2009
21. Mathur A, Luberice K, Paul H, et al: Increasing body mass index portends abbreviated survival following pancreatoduodenectomy for pancreatic adenocarcinoma. Am J Surg 209:969-973, 2015
22. McWilliams RR, Matsumoto ME, Burch PA, et al: Obesity adversely affects survival in pancreatic cancer patients. Cancer 116:5054-5062, 2010
23. Pelucchi C, Galeone C, Polesel J, et al: Smoking and body mass index and survival in pancreatic cancer patients. Pancreas 43:47-52, 2014
24. Balentine CJ, Enriquez J, Fisher W, et al: Intraabdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 14:1832-1837, 2010
25. Choi Y, Oh DY, Kim TY, et al: Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index. PLoS One 10:e0139749, 2015
26. Mathur A, Franco ES, Leone JP, et al: Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma. HPB (Oxford) 15:504-510, 2013
27. Siegel AB, Lim EA, Wang S, et al: Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation 94:539-543, 2012
28. Utsunomiya T, Okamoto M, Kameyama T, et al: Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World J Gastroenterol 14:1553-1558, 2008
29. Ohki T, Tateishi R, Shiina S, et al: Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut 58:839-844, 2009
30. Fujiwara N, Nakagawa H, Kudo Y, et al: Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131-140, 2015
31. Siegel AB, Wang S, Jacobson JS, et al: Obesity and microvascular invasion in hepatocellular carcinoma. Cancer Invest 28:1063-1069, 2010
32. Sinicrope FA, Foster NR, Yothers G, et al: Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 119:1528-1536, 2013
33. Meyerhardt JA, Catalano PJ, Haller DG, et al: Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98:484-495, 2003
34. Meyerhardt JA, Tepper JE, Niedzwiecki D, et al: Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: Findings from Intergroup Trial 0114. J Clin Oncol 22:648-657, 2004
35. You JF, Tang R, Changchien CR, et al: Effect of body mass index on the outcome of patients with rectal cancer receiving curative anterior resection: Disparity between the upper and lower rectum. Ann Surg 249:783-787, 2009
36. Renfro LA, Grothey A, Xue Y, et al. ACCENTbased web calculators to predict recurrence and overall survival in stage III colon cancer. J Natl Cancer Inst 106: dju333, 2014
37. Miyamoto Y, Baba Y, Sakamoto Y, et al: Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22:2663-2668, 2015
38. Gonzalez MC, Pastore CA, Orlandi SP, et al: Obesity paradox in cancer: New insights provided by body composition. Am J Clin Nutr 99:999-1005, 2014
39. Lajous M, Bijon A, Fagherazzi G, et al: Body mass index, diabetes, and mortality in French women: Explaining away a "paradox" Epidemiology 25:10-14, 2014
40. Banack HR, Kaufman JS: The obesity paradox: Understanding the effect of obesity on mortality among individuals with cardiovascular disease. Prev Med 62:96-102, 2014
41. Power ML, Schulkin J: Sex differences in fat storage, fat metabolism, and the health risks from obesity: Possible evolutionary origins. Br J Nutr 99:931-940, 2008
42. Lee CS, Murphy DJ, McMahon C, et al: Visceral adiposity is a risk factor for poor prognosis in colorectal cancer patients receiving adjuvant chemotherapy. J Gastrointest Cancer 46:243-250, 2015
43. Ballian N, Lubner MG, Munoz A, et al: Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma. J Surg Oncol 105:365-370, 2012
44. Haydon AM, Macinnis RJ, English DR, et al: Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 55:62-67, 2006
45. Prizment AE, Flood A, Anderson KE, et al: Survival of women with colon cancer in relation to precancer anthropometric characteristics: The Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 19:2229-2237, 2010
46. Sebio A, Gerger A, Matsusaka S, et al: Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer. Pharmacogenet Genomics 25:30-37, 2015
47. Liesenfeld DB, Grapov D, Fahrmann JF, et al: Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: The ColoCare study. Am J Clin Nutr 102:433-443, 2015
48. Campbell PT, Newton CC, Dehal AN, et al: Impact of body mass index on survival after colorectal cancer diagnosis: The Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 30:42-52, 2012
49. Pelser C, Arem H, Pfeiffer RM, et al: Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the National Institutes of Health (NIH)-AARP Diet and Health Study. Cancer 120:1540-1547, 2014
50. Renfro LA, Loupakis F, Adams RA, et al: Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database. J Clin Oncol 34:144-150, 2016
51. Lieffers JR, Mourtzakis M, Hall KD, et al: A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: Contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr 89:1173-1179, 2009
52. Van Vledder MG, Levolger S, Ayez N, et al: Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99:550-557, 2012
53. Ghiringhelli F, Vincent J, Guiu B, et al: Bevacizumab plus FOLFIRI-3 in chemotherapy-refractory patients with metastatic colorectal cancer in the era of biotherapies. Invest New Drugs 30:758-764, 2012
54. Guiu B, Petit JM, Bonnetain F, et al: Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut 59:341-347, 2010
55. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, et al: Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 46:1483-1488, 2003
56. Curet MJ: Special problems in laparoscopic surgery. Previous abdominal surgery, obesity, and pregnancy. Surg Clin North Am 80:1093-1110, 2000
57. Dindo D, Muller MK, Weber M, et al: Obesity in general elective surgery. Lancet 361:2032-2035, 2003
58. Griggs JJ, Mangu PB, Anderson H, et al: Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 30:1553-1561, 2012
59. Brown JC, Schmitz KH: The prescription or proscription of exercise in colorectal cancer care. Med Sci Sports Exerc 46:2202-2209, 2014
60. Rock CL, Doyle C, Demark-Wahnefried W, et al: Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:243-274, 2012
61. Schmitz KH, Courneya KS, Matthews C, et al: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409-1426, 2010
62. Denlinger CS, Ligibel JA, Are M, et al: Survivorship: Healthy lifestyles, version 2.2014. J Natl Compr Canc Netw 12:1222-1237, 2014
63. Meyerhardt JA, Niedzwiecki D, Hollis D, et al: Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 298:754-764, 2007
64. Befort CA, Klemp JR, Austin HL, et al: Outcomes of a weight loss intervention among rural breast cancer survivors. Breast Cancer Res Treat 132:631-639, 2012
65. Gudzune KA, Doshi RS, Mehta AK, et al: Efficacy of commercial weight-loss programs: An updated systematic review. Ann Intern Med 162:501-512, 2015
66. Marshall SJ, Levy SS, Tudor-Locke CE, et al: Translating physical activity recommendations into a pedometer-based step goal: 3000 steps in 30 minutes. Am J Prev Med 36:410-415, 2009
67. Donnelly JE, Blair SN, Jakicic JM, et al: American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 41:459-471, 2009
68. Silver JK, Baima J, Mayer RS: Impairmentdriven cancer rehabilitation: An essential component of quality care and survivorship. CA Cancer J Clin 63:295-317, 2013
69. Pedersen BK, Febbraio MA: Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457-465, 2012
70. Park J, Morley TS, Kim M, et al: Obesity and cancer-mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 10:455-465, 2014
71. Goodwin PJ: Obesity and breast cancer outcomes: How much evidence is needed to change practice? J Clin Oncol 34:646-648, 2016
72. Ballman KV. Biomarker: Predictive or prognostic? J Clin Oncol 33:3968-3971, 2015
73. Brändstedt J, Wangefjord S, Nodin B, et al: Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: A cohort study. Biol Sex Differ 3:23, 2012
74. Meyerhardt JA, Heseltine D, Niedzwiecki D, et al: Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803. J Clin Oncol 24:3535-3541, 2006
75. Physical Activity Guidelines Advisory Committee: Physical Activity Guidelines Advisory Committee Report, 2008. Washington, DC, US Department of Health and Human Services, 2008